Merck nelle notizie
La scienza all'avanguardia salva vite
Tamtam ha trovato 20 articoli recenti su Merck.
- Merck’s injectable Keytruda barred in Europe (MRK:NYSE)
- Merck’s New Keytruda Shot Blocked in Europe After Court Loss
- Dutch court bars Merck's Keytruda SC in eight European markets in Halozyme patent case
- Tempus Announces Multi-Year Collaboration with Moderna and Merck
- Tempus AI Doubles Down On Moderna and Merck Cancer Vaccine Infrastructure
- Better Dividend for Retirees: AbbVie vs. Merck
- Merck price target raised to $165 from $150 at JPMorgan
- Merck’s antibody impresses with ‘highly competitive’ data in chronic skin disease
- Merck business unit opens R&D facility in Sheboygan Falls
- Moderna, Merck Rally On Cancer Vaccine Promise. But Is The Multi-Billion-Dollar Hype Real?
- Moderna Soars On Cancer Vaccine. Is mRNA Ready For Prime Time?
- Merck’s anti-TL1A antibody secures a win in ph. 2 hidradenitis suppurativa trial
- Why Merck (MRK) Dipped More Than Broader Market Today
- Why Merck (MRK) Dipped More Than Broader Market Today
- Merck pulls antibiotic for multidrug-resistant infections from US market
- Merck, Daiichi Sankyo retract accelerated approval request for lung cancer ADC
- AstraZeneca, Merck, Novo deals inject fresh global momentum into Chinese biotech
- Merck, SciBrunch Launch Up-to-$2.13B Collaboration to Develop Preclinical KRAS-Inhibiting Molecular Glue
- Merck pulls antibiotic from US market
- Merck, Daiichi scrap FDA application for B7-H3 ADC in lung cancer
Articoli raccolti da Tamtam e conservati quando riguardano l'azienda, dal più recente. Ognuno rimanda alla sua fonte.
Vendi ad aziende come Merck?
Tamtam trova le aziende in linea con il tuo cliente ideale, analizza ogni account e ti dice chi contattare e quando.
Trova aziende simili